-
Mashup Score: 0UroGen Pharma - 12 month(s) ago
At UroGen, making the impossible possible for patients with urological cancers is a reality, not just an idea.
Source: www.urogen.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Guidelines - American Urological Association - 12 month(s) ago
AUA Cookie Policy and AgreementWe use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand where our visitors are coming from in an effort to continue to serve your needs.
Source: www.auanet.orgCategories: General Medicine News, Latest HeadlinesTweet-
#AUA23 breaking news! @JELMYTO is part of the new #AUAGuidelines, now published online. See the latest recommendations from the experts. https://t.co/BiZttO0F46 #Sponsored #Urology #UroOncology https://t.co/0N6aZeUIVL
-
-
Mashup Score: 0JELMYTO® (mitomycin) for pyelocalyceal solution - 1 year(s) ago
JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients
Source: www.jelmyto.comCategories: General Medicine News, Latest HeadlinesTweet-
Get fresh coffee and a fresh perspective on @JELMYTO at the @UroGenPharma booth! https://t.co/CCNr7Rh2uZ #Urology #UroOncology #Sponsored #AUA23 https://t.co/sn40kSFfQK
-
-
Mashup Score: 1UroGen Pharma - 1 year(s) ago
At UroGen, making the impossible possible for patients with urological cancers is a reality, not just an idea.
Source: www.urogen.comCategories: General Medicine News, Latest HeadlinesTweet-
Heading to #AUA23? @UroGenPharma welcomes you to Chicago! Check out The Bean, aka Cloud Gate, and then come by our booth for another experience that could inspire self-reflection. https://t.co/gmx17iFw7o #Urology #UroOncology #Sponsored https://t.co/2gGkUDz6QO
-
-
Mashup Score: 0JELMYTO® (mitomycin) for pyelocalyceal solution - 1 year(s) ago
JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients
Source: www.jelmyto.comCategories: General Medicine News, Latest HeadlinesTweet-
Join us at #AUA23 Friday 4/28 at 12:30 PM CDT for AN ADAPTABLE APPROACH: IS JELMYTO APPROPRIATE ACROSS PRESENTATIONS AND PRACTICE PATTERNS? Lunch and refreshments served! Product Theater in The Square. https://t.co/VdKHWlGCi1 #Urology #UroOncology #Sponsored https://t.co/qcJvVdp5dI
-
-
Mashup Score: 0JELMYTO® (mitomycin) for pyelocalyceal solution - 1 year(s) ago
JELMYTO is the first and only FDA-approved treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients
Source: www.jelmyto.comCategories: General Medicine News, Latest HeadlinesTweet-
Don’t miss this #AUA23 Product Theater with @Dr_Jen_Linehan and Dr. Sandip M Prasad on @JELMYTO and unique patient cases. Lunch and refreshments served! Friday, April 28, 12:30 PM CDT. Product Theater in The Square. https://t.co/gsZTcAGDkv #UroOncology #Sponsored https://t.co/lFqzGotJie
-
-
Mashup Score: 0Abstracts - EMUC22 - 2 year(s) ago
Submit research in oncology to be considered for EMUC22. Topics include prostate cancer, bladder cancer, RCC, testicular and penile cancers.
Source: EMUC22Categories: Latest Headlines, UrologyTweet-
The abstract deadlines for EMUC22 and ESUI22 close TONIGHT! Submit your original research on #urooncology and imaging before 23.59 CEST! Submit your EMUC22 abstract: https://t.co/WWO4Somuva Submit your ESUI22 abstract: https://t.co/xeq6WAqGvh https://t.co/f4r5qzU12h
-
-
Mashup Score: 0
“We…just need to apply operational efficiencies that are utilized in other industries [to] health care,” says Shirley Lee, CRNP-FNP, MPH.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
How remote patient navigators can help with management of prostate cancer https://t.co/aOQQjqAY1G #urology #urologist #pcsm #prostatecancer #urooncology
-
-
Mashup Score: 0
Combination therapy with the novel TKI sitravatinib and the anti–PD-1 immune checkpoint inhibitor nivolumab showed promising efficacy and safety in patients with clear cell renal cell carcinoma and progression after antiangiogenic therapy.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Combination therapy with nivolumab and the novel TKI sitravatinib showed promise in patients with renal cell carcinoma and progression after antiangiogenic therapy https://t.co/VN1NHoJsas #urology #urologist #kidneycancer #urooncology @PavlosMsaouel @MDAndersonNews
-
-
Mashup Score: 0
“Urachal carcinoma is a rare and aggressive malignancy. The low incidence of the disease results in limited large-scale clinical trials that could provide standardized guidelines for its diagnosis and management,” write Christopher Pieczonka, MD, and Peter Fioramonti, BS.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Presentation, diagnosis, and management of a rare case of urachal adenocarcinoma https://t.co/pXzw8l1iVg #urology #urologist #guoncology #urooncology @griffoncanisius
-
The only thing we love more than #AUA at @UroGenPharma is getting back to work improving patients' lives. Here's to the work #Urologists and #UroOncologists do every day. See you out there! https://t.co/28QUHXfx4D #Urology #UroOncology #Sponsored #AUA23 https://t.co/LOj2S71jye